Get the Stockscreener App
0.60
2.04%
0.012
Galmed Pharmaceuticals Ltd stock is traded at $0.60, with a volume of 28,262.
It is up +2.04% in the last 24 hours and down -9.31% over the past month.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.
See More
Previous Close:
$0.588
Open:
$0.597
24h Volume:
28,262
Relative Volume:
0.46
Market Cap:
$3.95M
Revenue:
-
Net Income/Loss:
$-8.70M
P/E Ratio:
-0.1702
EPS:
-3.5262
Net Cash Flow:
$-6.34M
1W Performance:
-1.91%
1M Performance:
-9.31%
6M Performance:
-56.52%
1Y Performance:
-65.91%
1-Day Range:
$0.597
$0.615
1-Week Range:
$0.5706
$0.6343
52-Week Range:
$0.5025
$2.68
Galmed Pharmaceuticals Ltd Stock (GLMD) Company Profile
Name
Galmed Pharmaceuticals Ltd
Sector
Industry
Phone
-
Address
-
Compare GLMD vs VRTX, REGN, ALNY, ARGX, INSM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GLMD
Galmed Pharmaceuticals Ltd
|
0.60 | 3.95M | 0 | -8.70M | -6.34M | -3.5262 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Galmed Pharmaceuticals Ltd Stock (GLMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-22-20 | Downgrade | B. Riley FBR | Buy → Neutral |
| Feb-04-20 | Initiated | Craig Hallum | Buy |
| Jan-30-20 | Resumed | Cantor Fitzgerald | Overweight |
| Dec-02-19 | Initiated | Canaccord Genuity | Buy |
| Dec-12-18 | Initiated | B. Riley FBR | Buy |
| Aug-02-18 | Reiterated | Maxim Group | Buy |
| Jul-13-18 | Initiated | Stifel | Buy |
| Jul-12-18 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-12-18 | Reiterated | H.C. Wainwright | Buy |
| Mar-15-18 | Upgrade | Maxim Group | Hold → Buy |
| Feb-14-18 | Downgrade | Maxim Group | Buy → Hold |
| Feb-12-18 | Reiterated | H.C. Wainwright | Buy |
| Nov-15-17 | Initiated | ROTH Capital | Buy |
| Aug-08-17 | Reiterated | H.C. Wainwright | Buy |
| Jul-31-17 | Reiterated | Maxim Group | Buy |
| Aug-01-16 | Reiterated | Maxim Group | Buy |
| Jul-06-16 | Resumed | ROTH Capital | Buy |
| Mar-28-16 | Resumed | H.C. Wainwright | Buy |
| Jun-23-15 | Initiated | H.C. Wainwright | Buy |
| May-06-15 | Initiated | Sun Trust Rbsn Humphrey | Buy |
View All
Galmed Pharmaceuticals Ltd Stock (GLMD) Latest News
Sectors Review: Can Galmed Pharmaceuticals Ltd deliver consistent dividendsMarket Rally & Low Risk Growth Stock Ideas - baoquankhu1.vn
Galmed (GLMD) director David Sidransky reports initial share and option holdings - Stock Titan
Galmed (GLMD) CFO details Ordinary Share, option and RSU holdings - Stock Titan
[Form 3] Galmed Pharmaceuticals Ltd. In... - Stock Titan
Galmed Pharmaceuticals (NASDAQ: GLMD) CAO reports shares, options and RSUs - Stock Titan
Galmed Pharmaceuticals Ltd. (GLMD) CSO details option holdings - Stock Titan
Galmed (GLMD) director Amir Poshinski details shares, RSUs and options - Stock Titan
Galmed (GLMD) director discloses multiple stock option grants - Stock Titan
Aug Chart Watch: Will Galmed Pharmaceuticals Ltd. stock maintain dividend yieldShort Setup & Advanced Swing Trade Entry Plans - Naître et grandir
Smart Money: Is Galmed Pharmaceuticals Ltd stock a good dividend stockMarket Growth Review & Reliable Price Breakout Signals - baoquankhu1.vn
Galmed Pharmaceuticals Shares Edge Higher Following CEO’s Positive Update - MSN
Galmed Pharmaceuticals Shareholders Approve Proposal at Special Meeting - TipRanks
Galmed Pharmaceuticals (NASDAQ: GLMD) shareholders back proposal at March 5 special meeting - Stock Titan
Galmed Pharmaceuticals Adjourns Special Shareholder Meeting for Lack of Quorum - TipRanks
Galmed Pharmaceuticals (GLMD) adjourns shareholder meeting and resets date - Stock Titan
Form 6K Galmed Pharmaceuticals Ltd. For: 4 March By Investing.com - Investing.com Canada
GLMD.O Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
GLMD Should I Buy - Intellectia AI
Buyout Rumor: Will Galmed Pharmaceuticals Ltd benefit from government policyWeekly Trend Report & Fast Momentum Entry Tips - baoquankhu1.vn
GLMD PE Ratio & Valuation, Is GLMD Overvalued - Intellectia AI
Can Galmed Pharmaceuticals Ltd. ride the EV waveWeekly Trend Recap & Daily Profit Focused Screening - mfd.ru
Why Galmed Pharmaceuticals Ltd. (GPH) stock is a must watch tickerTrade Ideas & Comprehensive Market Scan Reports - mfd.ru
Dip Buying: Why Galmed Pharmaceuticals Ltd. (GPH) stock is a must watch tickerTrade Risk Assessment & Stepwise Swing Trade Plans - mfd.ru
Can Galmed Pharmaceuticals Ltd. deliver consistent dividends2025 Price Targets & Long-Term Growth Portfolio Plans - mfd.ru
What’s the RSI of Galmed Pharmaceuticals Ltd. stockTreasury Yields & Community Consensus Picks - mfd.ru
Galmed Pharmaceuticals schedules special shareholder meeting for March 4 - Investing.com Nigeria
Galmed Pharmaceuticals Sets March 4 Vote on Reverse Stock Split to Address Nasdaq Listing Deficiency - TipRanks
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Aug Summary: Will Galmed Pharmaceuticals Ltd benefit from government policyJuly 2025 Weekly Recap & Daily Chart Pattern Signal Reports - baoquankhu1.vn
Galmed Pharmaceuticals Receives Nasdaq Minimum Bid Price Deficiency Notice - TipRanks
Galmed Pharmaceuticals receives Nasdaq minimum bid price notice - Investing.com
Galmed Pharmaceuticals Announces Receipt of Nasdaq Minimum Bid Price Notification - PR Newswire
Published on: 2026-01-20 07:51:30 - bollywoodhelpline.com
Market Review: Can Home Bancorp Inc maintain its current growth rateQuarterly Portfolio Summary & Consistent Profit Alerts - baoquankhu1.vn
How volatile is Galmed Pharmaceuticals Ltd stockTrade Analysis Summary & Scalable Portfolio Growth Methods - baoquankhu1.vn
Price Action: What are IBKRs technical support levelsQuarterly Trade Report & Short-Term High Return Strategies - baoquankhu1.vn
Galmed Pharmaceuticals (NASDAQ:GLMD) Share Price Crosses Below 50-Day Moving Average – Should You Sell? - Defense World
Trade Recap: Is Galmed Pharmaceuticals Ltd stock a good dividend stock2025 Analyst Calls & Long-Term Growth Stock Strategies - baoquankhu1.vn
Chart Watch: Will Galmed Pharmaceuticals Ltd benefit from government policyWeekly Investment Report & Smart Investment Allocation Insights - baoquankhu1.vn
Stock Report: Is Galmed Pharmaceuticals Ltd in a long term uptrendJuly 2025 Market Mood & Daily Growth Stock Tips - baoquankhu1.vn
Galmed Pharmaceuticals Secures Shareholder Approval at Annual Meeting - MSN
Volume Report: How Galmed Pharmaceuticals Ltd GPH stock expands through international marketsPortfolio Value Report & Free Verified High Yield Trade Plans - Bộ Nội Vụ
Will Galmed Pharmaceuticals Ltd. stock outperform Dow Jones indexPortfolio Value Report & Verified Short-Term Plans - ulpravda.ru
What makes Galmed Pharmaceuticals Ltd. (GPH) stock appealing to growth investorsMarket Risk Analysis & Fast Exit and Entry Trade Guides - Улправда
What technical charts say about Galmed Pharmaceuticals Ltd. stockMarket Performance Summary & Stepwise Entry and Exit Trade Signals - ulpravda.ru
How Galmed Pharmaceuticals Ltd. stock reacts to job market data2025 Performance Recap & Low Drawdown Momentum Ideas - Улправда
Can Galmed Pharmaceuticals Ltd. stock surprise with earnings upsideJuly 2025 Big Picture & Advanced Swing Trade Entry Alerts - Улправда
How Galmed Pharmaceuticals Ltd. (GPH) stock expands through international marketsJuly 2025 Review & Free Technical Confirmation Trade Alerts - Улправда
Is Galmed Pharmaceuticals Ltd. (GPH) stock worth buying before Fed actionJuly 2025 Drop Watch & Smart Investment Allocation Insights - Улправда
Published on: 2026-01-09 00:35:39 - ulpravda.ru
Galmed Pharmaceuticals Ltd.Ordinary Shares (NQ: GLMD - FinancialContent
Galmed Pharmaceuticals Ltd Stock (GLMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):